HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].

Abstract
Twelve women with hydatidiform mole were studied between 12 and 20 weeks-gestation. The level of SP1 was determined by radioimmunologic method. The author found statistically significant increase of SP1 over 90th percentile of gestational age (p less than 0.001). Examining the level of SP1 after evacuation of hydatidiform mole it was established that SP1 was eliminated more quickly than human chorionic gonadotropin (HCG) in urine during early pregnancy. Quite the contrary was discovered in women with advanced pregnancy, in whom the concentration of SP1 disappeared more slowly, while HCG was eliminated for a shorter time. The observed dissociation in elimination of SP1 and HCG showed that the combined examination of HCG and SP1 provided better information in the follow-up of women with trophoblastic disease. The author think that treatment of trophoblastic disease should continue till complete elimination both of HCG and SP1.
AuthorsN Radikov
JournalAkusherstvo i ginekologiia (Akush Ginekol (Sofiia)) Vol. 28 Issue 2 Pg. 15-9 ( 1989) ISSN: 0324-0959 [Print] Bulgaria
Vernacular TitleProuchvaniia na serumnata kontsentratsiia na spetsifichniia beta 1-glikoprotein pri trofoblastna bolest.
PMID2548413 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Chorionic Gonadotropin
  • Pregnancy Proteins
  • Pregnancy-Specific beta 1-Glycoproteins
Topics
  • Adolescent
  • Adult
  • Chorionic Gonadotropin (urine)
  • Female
  • Humans
  • Hydatidiform Mole (blood, urine)
  • Pregnancy
  • Pregnancy Proteins (analysis)
  • Pregnancy Trimester, First
  • Pregnancy Trimester, Second
  • Pregnancy-Specific beta 1-Glycoproteins (analysis)
  • Trophoblastic Neoplasms (blood, urine)
  • Uterine Neoplasms (blood, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: